
Gainers
- IGM Biosciences, Inc. (NASDAQ:IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ:SNY) and IGM Biosciences signed an exclusive worldwide collaboration agreement for IgM antibodies agonists against three oncology targets and three immunology/inflammation targets.
- PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) jumped 46.1% to close at $1.68.
- China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) climbed 45.4% to close at $0.2937 on Tuesday after declining 9% on Monday.
- Oblong Inc. (NASDAQ:OBLG) jumped 45% to close at $0.8410. Oblong posted Q4 net loss of $2.71 million.
- Clever Leaves Holdings Inc. (NASDAQ:CLVR) gained 40.3% to settle at $2.68.
- MicroVision, Inc. (NASDAQ:MVIS) climbed 32.8% to close at $5.55. Microvision was granted US patent 'Alteration of resonant mode frequency response in mechanically resonant device.'
- ECMOHO Limited (NASDAQ:MOHO) gained 28% to settle at $0.32.
- Dave Inc. (NASDAQ:DAVE) climbed 27.5% to close at $8.31.
- LianBio (NASDAQ:LIAN) gained 27.5% to settle at $3.57.
- Kinnate Biopharma Inc. (NASDAQ:KNTE) surged 25.9% to close at $13.06. Kinnate Biopharma posted FY loss of $2.06 per share.
- ShiftPixy, Inc. (NASDAQ:PIXY) gained 25.6% to settle at $0.8399.
- Blackboxstocks Inc. (NASDAQ:BLBX) gained 25.6% to close at $2.45.
- Randolph Bancorp, Inc. (NASDAQ:RNDB) rose 25.4% to close at $26.44 after Hometown Financial Group announced plans to acquire Randolph Bancorp for $27 per share in cash.
- Robinhood Markets, Inc. (NASDAQ:HOOD) climbed 24.2% to settle at $15.91. Robinhood Markets on Tuesday unveiled extended trading hours for its brokerage platform, building on the company's aim to make investing more accessible for all.
- Auddia Inc. (NASDAQ:AUUD) gained 23.2% to close at $2.28.
- Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) rose 22.7% to close at $4.59 after the company reported better-than-expected Q4 sales results and issued FY22 sales guidance above analyst estimates.
- Electric Last Mile Solutions, Inc. (NASDAQ:ELMS) jumped 22.5% to settle at $1.58.
- NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) surged 22% to close at $4.66.
- Molecular Templates, Inc. (NASDAQ:MTEM) gained 21.1% to close at $3.27 as the company posted a narrower quarterly loss.
- The Lovesac Company (NASDAQ:LOVE) shares gained 20.8% to close at $56.99. Lovesac reported fourth-quarter FY22 sales growth of 51.3% year-on-year, to $196.2 million, beating the consensus of $174.33 million.
- Grid Dynamics Holdings, Inc. (NASDAQ:GDYN) rose 20.5% to close at $14.26.
- Nielsen Holdings plc (NYSE:NLSN) gained 20.3% to close at $26.72 after the company announced it will be acquire by a private equity consortium led by Evergreen Coast Capital and Brookfield Business Partners for $28 per share.
- Team, Inc. (NYSE:TISI) jumped 19.4% to settle at $1.91.
- Viracta Therapeutics, Inc. (NASDAQ:VIRX) gained 18.4% to close at $4.75.
- Guardforce AI Co., Limited (NASDAQ:GFAI) climbed 17.8% to close at $1.39 after the company announced it is in the process of establishing subsidiaries in Dubai and Australia, with a focus on Robotics as a Service rollout initiatives.
- Genenta Science S.p.A. (NASDAQ:GNTA) gained 16.8% to close at $7.30.
- Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) rose 16.3% to settle at $12.68. Monte Rosa Therapeutics reported a Q4 net loss of $23.4 million.
- TRxADE HEALTH, Inc. (NASDAQ:MEDS) gained 14.4% to close at $2.62 after the company reported Q4 earnings results.
- Gelesis Holdings, Inc. (NYSE:GLS) rose 13% to close at $5.49. Gelesis Holdings recently reported FY EPS of $85.22.
- Hycroft Mining Holding Corporation (NASDAQ:HYMC) shares climbed 11.6% to close at $2.59 after jumping 80% on Monday.
- NexImmune, Inc. (NASDAQ:NEXI) rose 8.6% to close at $3.52 after declining 24% on Monday.
- Nautilus, Inc. (NYSE:NLS) gained 8.3% to close at $4.31.